There is little doubt that advanced countries in the first half of 2022 will pull back, albeit partially, on the ultra-stimulative monetary policies they have pursued for several years. What is more consequential, yet less certain, is when and how this will lead to a meaningful tightening of financial conditions and what the spillover effects will be for the ...

The biotech sector is more than 40% down from its high last February, while the major pharmaceutical firms are flush with cash. That sounds like the ideal condition for dealmaking. But what if biotech boards and shareholders want takeover bids at yesterday’s sky-high prices? A 2020 study by JP Morgan Chase & Co. analysts found that when markets fall, a ...

One of the most abundant and essential ingredients in electric vehicle batteries is beginning to experience demand pressures, showing how supply chain troubles are getting deeper and the value chain even more expensive. Tesla Inc last week signed a deal with Australian mining company Syrah Resources Ltd to procure materials from the firm’s Louisiana operations, with the raw inputs coming ...